Executive Summary Global Atopic Dermatitis Market was valued at USD 9095.16 Million in the year 2018. Rise in pollution levels, growing urbanization, unhealthy lifestyle, increase in number of allergies backed by hygiene hypothesis are the factors leading to increasing prevalence of atopic dermatitis globally. It is the most common form of eczema, for which no permanent cure is available but novel therapies are being introduced in the market to subdue the itch and discomfort associated with AD.
Topical therapy is the highlight of the AD market, because of easy application on the skin and higher effectiveness. But with the advent of first biologic targeted therapy Dupixent in 2017 (Collaboration between Sanofi and Regeneron) in major regions of the world, AD market has experienced major revenue boost and it is expected to grow exponentially in the forecast period. Moreover Atopic Dermatitis market is also expected to grow because of elaborate pipeline by pharmaceutical companies. Also, by end user hospital may experience maximum growth as number of patient visit for AD, asthma, allergy and hay fever treatment is expected to increase during the forecast period.
Among the regions, Asia Pacific, followed by Americas and Europe will experience the highest growth rate owing to increase in prevalence as well as per capita expenditure on healthcare.
Scope of the Report • The report analyses Atopic Dermatitis Market By Therapy Segment (Biologic Therapy, Topical Therapy, Oral Therapy, Photo Therapy). • The report assesses the Atopic Dermatitis market By End User (Hospital, Clinics, Research Labs). • The Global Atopic Dermatitis Market has been analysed By Region (Americas, Europe, Asia Pacific, Rest of the world) and By Country (USA, Canada, Mexico, Brazil, Germany, UK, Japan, China, India, Australia). • The key insights of the report have been presented through the frameworks of SWOT and Market Attractiveness charts. The attractiveness of the market has been presented by Region, Therapy and by End User. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report. • The report provides a detailed pipeline analysis of drugs being developed to cure the problem of atopic dermatitis. • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Sanofi, Regeneron, Pfizer, Allergan, Abbvie, Leo Pharma, Lilly, Aclaris, Anaptys Bio, Dermira. • The report presents the analysis of Atopic Dermatitis market for the historical period of 2014-2018 and the forecast period of 2019-2024.
Key Target Audience • Pharmaceutical Companies • Consulting and Advisory Firms • Medical Practitioners • Regulatory Authorities
Our reports have been used by over 10K customers, including:
285 pages •
By Asia Market Information & Development Company
• May 2020
China’s demand for Asthma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...
470 pages •
By The Business Research Company
• May 2020
Respiratory Masks (N95 Respirators, Surgical Masks, And Others) Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth report provides the strategists, marketers and senior management with the critical information they need to assess how the global Respiratory Masks (N95 Respirators, Surgical Masks, And Others)...
Transthyretin - Pipeline Review, H1 2020 Summary Transthyretin (ATTR or Prealbumin or TBPA or TTR) – Transthyretin is a transport protein. It transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The diseases caused by mutations...
Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H1, 2020 Summary This clinical trial report, “Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H1, 2020" provides an overview of Allergic Rhino-Conjunctivitis Clinical trials scenario.This report provides top line data relating...
319 pages •
By The Business Research Company
• Apr 2020
Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth report provides the strategists, marketers and senior management with the critical information they need to assess the demand for anti-asthmatics and COPD drugs market which play a critical role in the treatment of patients with...
The transdermal drug delivery system market was valued at US$ 6,063.85 million in 2019 and is projected to reach US$ 8,415.04 million by 2027; it is expected to grow at a CAGR of 4.3% during 2020-2027. The growth of the transdermal drug delivery system market is mainly attributed to factors such as the increasing prevalence of chronic diseases,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.